Research Alliances
| Focus: | Research Alliances |
|---|---|
| Type: | database (supplied by e-mail as setup.exe file) |
| No. of deals: | 340 |
| No. of companies: | 242 |
| Years covered: | 1996 – 2011 |
| Price: | € 975 ex VAT (if applicable) |
| System requirements: | Windows 2000/Windows XP/Windows Vista/7 |
| Publisher: | PharmaPlus Consultancy B.V. |
Are you about to enter deal negotiations for your research alliance?
Use PharmaDeal Financials Research Alliances to benchmark your next research deal
PharmaDeal Financials Research Alliances
- Deal specifics on almost 350 research alliance deals
- Deal making trends since 1996
- Big pharma licensees like Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson and Sanofi
- All indications and compound classes including antibodies, GPCR modulators, ion channel modulators, kinase inhibitors and stem cells
- 12% antibody-related deals
- Upfront payments from USD 0.25 million to USD 185 million
- Total milestones from USD 2 million to USD 1.4 billion
- Sales-related milestones up to USD 346 million per programme
Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research-filed), geographical territory, potential deal size, upfront, total milestones-regulatory milestones-sales milestones payments, profit sharing, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof.
Disease areas included in database
Autoimmune disorders, blood and forming organs, cardiovascular disorders, central nervous system disorders, dermatological disorders, eye disorders, inflammatory disorders, immunological disorders, infectious diseases, inflammatory disorders, liver disorders, metabolic disorders, musculoskeletal disorders, oncology, organ transplantation, peripheral nervous system disorders, respiratory disorders, urological disorders
Companies included in database
4-Antibody, Abbott Laboratories (Solvay Pharmaceuticals), Ablynx, Acadia Pharmaceuticals, Actelion, Addex Pharmaceuticals, Advinus Therapeutics, Aeolus Pharmaceuticals (Transcell Technologies), Affectis Pharmaceuticals, Agennix (GPC Biotech), Agios Pharmaceuticals, Aileron Therapeutics, Albany Molecular Research (ComGenex), Alectos Therapeutics, Allergan, Almirall, Alnylam Pharmaceuticals, Ambit Biosciences, Amgen (Tularik), Amorfix Life Sciences, Anacor Pharmaceuticals, Anadys Pharmaceuticals (Scriptgen Pharmaceuticals), Anaphore, Anchor Therapeutics, Applied Neurosolutions, ARCA Biopharma (Nuvelo/Hyseq), Archemix Corporation, Ardea Biosciences (IntraBiotics Pharmaceuticals), Argenta Discovery, ArQule, Array BioPharma, ARYX Therapeutics, Ascenta Therapeutics, Astellas Pharma (Fujisawa Pharmaceutical Co.), Astex Therapeutics (SuperGen), AstraZeneca (Cambridge Antibody Technology, MedImmune, Zeneca), Aurigene Discovery Technologies, Avanir Pharmaceuticals, AVEO Pharmaceuticals (GenPath Pharmaceuticals), Avila Therapeutics, Baxter, Bayer (Schering AG), Biogen Idec (Biogen, Idec Pharmaceuticals), Bionomics, Biota Holdings, Biotica Technology, BioTie Therapeutics (Elbion), Boehringer Ingelheim, Bristol-Myers Squibb (Adnexus Therapeutics, DuPont Pharmaceuticals, Medarex), Catalyst Biosciences, Celera Corporation (Axys Pharmaceuticals, Sequana Therapeutics), Celgene Corporation (Signal Pharmaceuticals), CellCentric, Celldex Therapeutics (CuraGen Corporation), Cellzome, Cephalon, CGI Pharmaceuticals, Chiesi Farmaceutici, Chroma Therapeutics, Cubist Pharmaceuticals, Curagen, CureVac, Curis, Cytokinetics, Cytori Therapeutics, Cytos Biotechnology, Daiichi-Sankyo (Ranbaxy Laboratories), Dainippon Sumitomo Pharma (Dainippon Pharmaceutical Co.), deCODE Genetics, Deltagen, Dicerna Pharmaceuticals, Discovery Partner International, Dyax Corporation, Dynavax Technologies Corporation, Elan Corporation, ElexoPharm, Eli Lilly & Company (SGX Pharmaceuticals), Endo Pharmaceuticals, Ensemble Discovery, Envoy Therapeutics, Epistem, Evotec, ExCaliard Pharmaceuticals, Exelixis, Extracta, Eyetech Pharmaceuticals, f-star, Facet Biotech Corporation (Protein Design Labs/Eos Biotechnology), Five Prime Pharmaceuticals, Forest Laboratories (Clinical Data (Avalon Pharmaceuticals)), Galapagos (Biofocus DPI), Genaera Corporation, Geneprot (Geneva Proteomics), Genmab, Gilead Sciences (CV Therapeutics), GlaxoSmithKline (Corixa, GeneLabs Technologies, GlaxoWellcome, SmithKline Beecham), Guandong Zhongsheng Pharmaceutical Co., Guilford Pharmaceuticals, Heptares Therapeutics, Hillcrest Therapeutics, Human Genome Sciences, Hydra Biosciences, Idenix Pharmaceuticals, Idera Pharmaceuticals (Hybridon), Immunogen, Inex Pharmaceutical Corporation, Inflazyme Pharmaceuticals (GlycoDesign), Ingenium Pharmaceuticals, Innogenetics, Intercell, Intercept Pharmaceuticals, Intrexon Corporation, Ipsen Pharma, Isis Pharmaceuticals, ItherX Pharmaceuticals (Immusol), Japan Tobacco, Johnson & Johnson (3-Dimensional Pharmaceuticals, Centocor, Janssen Biotech, Janssen, Pharmaceutica, Ortho McNeil, Tibotec), Karo Bio, Kinemed, Kissei Pharmaceutical Co., Kyowa Hakko Kirin (Kirin Brewery Co.), Leo Pharma, Lexicon Pharmaceuticals (Lexicon Genetics), LG Chemical, LG Life Sciences, Ligand Pharmaceuticals (Pharmacopeia), Lipoxen, Lundbeck, MacroGenics, Marina Biotech, Medicis Pharmaceutical Corporation, Medivir, Merck & Co. (Elitra Pharmaceuticals, Schering-Plough/NeoGenesis Pharmaceuticals, Organon, Sibia Neurosciences), Merck Serono (Ares-Serono, Merck KGaA, Serono), Metabasis Therapeutics, Metabolex, Metamark Genetics, MethylGene, Micromet, Mitsubishi Tanabe Pharma (Tanabe Seiyaku), Molecular Partners, Molecumetrics, MorphoSys, Mpex Pharmaceuticals, Myriad Genetics, Nerviano Medical Sciences, Neurocrine Biosciences, Neurogen Corporation, NeuroSearch, NovaDx International, Novartis, Nycomed (Altana/Byk Gulden), Ocinum Biosolutions (Gene Logic), Oncomed Pharmaceuticals, Onyx Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Orexo (Biolipox), Oscient Pharmaceuticals (Genome Therapeutics), OSI Pharmaceuticals, Oxford Biotherapeutics, PAION (CeNeS Pharmaceuticals/Cambridge Neuroscience), Palatin Technologies, Paratek Pharmaceuticals, Pfizer (Agouron Pharmaceuticals, ICAgen, Idun Pharmaceuticals. G.P. Searle & Co, Pharmacia Corporation, Warner-Lambert,Wyeth, Wyeth-Ayerst, American Home Products), Pharmasset, Pharminox, Pharnext, Phylogica, Pieris AG, Pierre Fabre, Plexxikon, Polyphor, Priaxon, Prima Biomed, Procter & Gamble, Proteus Biomedical, PTC Therapeutics, Purdue Pharma, Quanticel Pharmaceuticals, Quark Biotech, Questcor Pharmaceuticals (RiboGene), RaQualia Pharma, Regado Biosciences, Regeneron Pharmaceuticals, Regulus Therapeutics, Rigel Pharmaceuticals, Roche (Arius Research, Genentech, Memory Pharmaceuticals, Piramed), Sanofi (Fovea Pharmaceuticals, Genzyme Corporation (AnorMED), Hoechst Marion Roussel, Rhone-Poulenc Rorer, Sanofi Pasteur, Sanofi-Aventis, Sanofi-Synthélabo), Santaris Pharma, SARCode Corporation, Sareum Holdings, Scion Pharmaceuticals, Seikagaku Corporation, Sequenom, Servier, Siga Pharmaceuticals, Silence Therapeutics, Sirnaomics, Sunesis Pharmaceuticals, Suven Life Sciences, Sygnis Pharma (Lion Bioscience), Symphogen, Synis Pharma (Trega Biosciences), Synthetic Biologics (Adeona Pharmaceuticals), Taisho Pharmaceutical Co., Takeda Pharmaceutical Company (IDM Pharma/Immuno-Designed Molecules, Millennium Pharmaceuticals/LeukoSite), Tekmira Pharmaceuticals, Teva Pharmaceutical Industries (Pliva), Texas Biotechnology, Thallion Pharmaceuticals (Caprion Pharmaceuticals, Ecopia BioSciences), The Althexis Company, Theraclone Sciences, Tranzyme Pharma, UCB Pharma (Celltech/Oxford Glycosciences, Schwarz Pharma), Urogene, Verenium Corporation (Diversa Corporation), Vernalis (British Biotech, Pintex Pharmaceuticals), Vertex Pharmaceuticals, Viamet Pharmaceuticals, Viropharma, Vitae Pharmaceuticals, Vifor, Vivalis, Xencor, Xenon Pharmaceuticals, Xoma, Zacharon Pharmaceuticals, Zalicus (CombinatoRx), Zenyaku Kogyo, Zymeworks, ZymoGenetics
